Promis Neurosciences Inc.
Records under this name other than the patents Promis Neurosciences Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Back to Promis Neurosciences Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,779,629 | Compositions Comprising Cyclic Peptides Derived from an Abeta Peptide Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,286,469 | Humanized Antibodies Binding to Amyloid-Beta (A-BETA) Held by another company In force · High confidence | In force | High confidence | |
| US 12,071,472 | Methods of Reducing Amyloid Beta (A-BETA) Propagation and Toxicity Induced by A-Beta Oligomers Using Antibodies Specific to A-Beta Oligomers Formerly held In force · High confidence | In force | High confidence | |
| US 12,404,321 | Conformation-Specific Epitopes in Alpha-Synuclein, Antibodies Thereto and Methods Related Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,053,510 | FasR ANTIBODIES AND METHODS OF USE Lapsed on the fee record Ended Aug 21, 2026 · High confidence | Lapsed on the fee record | Ended Aug 21, 2026 | High confidence |
| US 8,709,422 | Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases Lapsed on the fee record Ended Apr 29, 2026 · Low confidence | Lapsed on the fee record | Ended Apr 29, 2026 | Low confidence |
| US 7,887,803 | Methods and compositions to treat misfolded-SOD1 mediated diseases Term ended Term ended Aug 12, 2025 · USPTO record | Term ended | Term ended Aug 12, 2025 | USPTO record |
| US 9,637,552 | Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated DIseases Lapsed on the fee record Ended May 2, 2025 · Low confidence | Lapsed on the fee record | Ended May 2, 2025 | Low confidence |
| US 9,523,697 | Detection of pathogenic abeta using an epitope protection assay Lapsed on the fee record Ended Dec 20, 2024 · USPTO record | Lapsed on the fee record | Ended Dec 20, 2024 | USPTO record |
| US 7,439,324 | ALS-specific peptide composition Term ended Term ended Dec 11, 2024 · USPTO record | Term ended | Term ended Dec 11, 2024 | USPTO record |